BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23053510)

  • 41. Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients.
    Leng FY; Liu JL; Liu ZJ; Yin JY; Qu HP
    J Microbiol Immunol Infect; 2013 Oct; 46(5):338-44. PubMed ID: 22921804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.
    Unsinger J; McGlynn M; Kasten KR; Hoekzema AS; Watanabe E; Muenzer JT; McDonough JS; Tschoep J; Ferguson TA; McDunn JE; Morre M; Hildeman DA; Caldwell CC; Hotchkiss RS
    J Immunol; 2010 Apr; 184(7):3768-79. PubMed ID: 20200277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy.
    Hennion-Tscheltzoff O; Leboeuf D; Gauthier SD; Dupuis M; Assouline B; Grégoire A; Thiant S; Guimond M
    Blood; 2013 Jun; 121(23):4684-93. PubMed ID: 23613523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon-
    Henriquez JE; Rizzo MD; Crawford RB; Gulick P; Kaminski NE
    J Pharmacol Exp Ther; 2018 Oct; 367(1):49-58. PubMed ID: 30026298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes.
    Barker BR; Parvani JG; Meyer D; Hey AS; Skak K; Letvin NL
    J Immunol; 2007 Sep; 179(6):3596-603. PubMed ID: 17785794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
    Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
    Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity.
    Kudernatsch RF; Letsch A; Guerreiro M; Löbel M; Bauer S; Volk HD; Scheibenbogen C
    Eur J Immunol; 2014 Dec; 44(12):3532-42. PubMed ID: 25231631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.
    Shubin NJ; Monaghan SF; Heffernan DS; Chung CS; Ayala A
    Crit Care; 2013 Nov; 17(6):R276. PubMed ID: 24289156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis.
    Ayala A; Chung CS; Song GY; Chaudry IH
    Cytokine; 2001 Apr; 14(1):37-48. PubMed ID: 11298491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency on antiretroviral therapy are associated with T-cell activation and senescence.
    Tanaskovic S; Fernandez S; Price P; French MA
    AIDS; 2014 Mar; 28(6):821-30. PubMed ID: 24499954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4
    Smith GA; Taunton J; Weiss A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
    Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
    Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool.
    Melchionda F; Fry TJ; Milliron MJ; McKirdy MA; Tagaya Y; Mackall CL
    J Clin Invest; 2005 May; 115(5):1177-87. PubMed ID: 15841203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
    Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
    Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.
    Simonetta F; Chiali A; Cordier C; Urrutia A; Girault I; Bloquet S; Tanchot C; Bourgeois C
    Eur J Immunol; 2010 Sep; 40(9):2528-38. PubMed ID: 20690182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
    Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
    J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.